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Human cathelicidin LL-37 enhance the
antibiofilm effect of EGCG on Streptococcus
mutans
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Abstract
Background: Streptococcus mutans forms biofilms as a resistance mechanism against antimicrobial agents in the
human oral cavity. We recently showed that human cathelicidin LL-37 exhibits inhibitory effects on biofilm formation
of S. mutans through interaction with lipoteichoic acid (LTA), but without antibacterial or biofilm dispersal abilities.
(−)-Epigallocatechin gallate (EGCG) is the most abundant constituent of tea catechins that has the greatest
anti-infective potential to inhibit the growth of various microorganisms and biofilm formation. Therefore, in this
study, we evaluated whether LL-37 interacts with EGCG to enhance the antibiofilm effect of EGCG on S. mutans
biofilm formation.
Methods: Clinical S. mutans strains (n = 10) isolated from children’s saliva were tested in a biofilm formation
assay. The antibiofilm effect of EGCG with and without LL-37 was analyzed by the minimum biofilm eradication
concentration assay and confirmed using field emission-scanning electron microscopy. In addition, the interaction
among EGCG, LL-37, and LTA of S. mutans was determined using quartz crystal microbalance analysis.
Results: EGCG killed 100 % of planktonic S. mutans within 5 h, inhibited biofilm formation within 24 h, and reduced
bacteria cells in preformed biofilms within 3 h at a concentration of 0.2 mg/mL. However, EGCG did not appear
to interact with LTA. LL-37 effectively enhanced the bactericidal activity of EGCG against biofilm formation and
preformed biofilms as determined by quantitative crystal violet staining and field emission-scanning electron
microscopy. In addition, quartz crystal microbalance analysis revealed that LL-37 interacted with EGCG and
promoted binding between EGCG and LTA of S. mutans.
Conclusions: We show that LL-37 enhances the antibiofilm effect of EGCG on S. mutans. This finding provides
new knowledge for dental treatment by using LL-37 as a potential antibiofilm compound.
Keywords: LL-37, EGCG, Streptococcus mutans, Biofilm
Background
Pathogenic bacteria can form biofilms that cause much
infectious disease in the human oral cavity. Among these
diseases, dental caries is one of the most ubiquitous
biofilm-dependent oral diseases worldwide, which
frequently occurs in both children and adults [1]. Oral
streptococci, including Streptococcus mutans and
Streptococcus sobrinus, are generally considered the
primary etiologic agents of dental caries [2, 3]. One of the
most well-documented virulence characteristics of S.
mutans is its ability to establish cariogenic biofilms on
tooth surfaces as an assembled extracellular matrix [4, 5].
Extracellular polymeric substances, especially water-
insoluble glucans, are the main constituents of the matrix
and can mediate S. mutans adherence [6, 7]. Other con-
stituents such as extracellular DNA [8] and lipoteichoic
acids (LTA) have also been found in high concentrations
in the matrix of cariogenic biofilms [9, 10].
Tea is the most frequently consumed beverage in the
world after water [11]. The antimicrobial activity of tea
was first demonstrated almost 100 years ago by
* Correspondence: yijie_guo@mail.xjtu.edu.cn; xujiru@mail.xjtu.edu.cn
†Equal contributors
1Department of Pathogenic Microbiology and Immunology, School of Basic
Medical Sciences, Xi’an Jiaotong University, Yanta West Road No.76, Xi’an
710061, ShaanXi, China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Guo et al. BMC Oral Health  (2016) 16:101 
DOI 10.1186/s12903-016-0292-y
McNaught [12]. Green tea (Camellia sinensis) is a non-
fermented tea that has more beneficial effects than black
tea or oolong tea [13]. It has been observed that catechin
components of green tea are responsible for its antibac-
terial activity, and (−)-epicatechin gallate, (−)-epigallo-
catechin (EGC), and (−)-epigallocatechin gallate (EGCG)
constitute the most important antibacterial agents of tea
catechins [14, 15].
EGCG is the most abundant constituent of tea catechins
that has the greatest anti-infective ability by inhibiting the
growth of various microorganisms [16], biofilm formation
[17], and quorum sensing [18, 19]. Xu et al. reported that
EGCG inhibits the growth of S. mutans, decreases gluco-
syltransferases activity, and suppresses gtf genes, which
are associated with bacterial biofilm formation [20, 21].
However, the effects of EGCG on biofilm and cariogenic
virulence factors of oral streptococci other than glucosyl-
transferases have not been well documented, especially
regarding its potential interaction with LTA.
The antibacterial peptide LL-37 is the only member of
the cathelicidin family found in humans. LL-37 is an 18-
kDa peptide [22] with 37 amino acid residues that start
with two leucines [23]. LL-37 is expressed in many tis-
sues and body fluids, such as saliva, gingiva, sweat, am-
niotic fluids, and seminal plasma [24]. It has been
reported that the intravital concentration of LL-37 is
about 86 μg/mL in seminal plasma of healthy donors
[25], and ranges from less than 1.2 to more than 80 μg/
mL in unstimulated and nonpurulent nasal secretions
[26], respectively. Cariogenic species, such as S. sobrinus,
Lactobacillus paracasei, and Actinomyces viscosus have
been reported to be resistant to LL-37 through growth
inhibition and bactericidal tests [27], especially when
biofilm formation occurred. We recently showed that
LL-37 has the ability to bind to LTA of S. mutans, inhi-
biting biofilm formation [28]. Therefore, in this study,
we evaluated whether LL-37 could be used as a binding
agent to enhance the interaction between EGCG and
LTA of S. mutans to increase the antibiofilm effect of
EGCG.
Methods
Bacterial strains and culture conditions
Ten clinical S. mutans strains isolated from children’s
saliva were kindly provided by Dr. E. Isogai [29]. Bac-
teria were grown in brain heart infusion (BHI) broth
(Merck KGaA, Darmstadt, Germany) for 24 h at 37 °C.
The present study was approved by the Ethics Commit-
tee of Xi’an Jiaotong University Faculty of Medicine
(XJTU2014-014).
Catechin and antimicrobial peptide
EGCG (NH020403) was purchased from Nagara Science
Co. Ltd. (Gifu, Japan). EGCG was dissolved in absolute
ethyl alcohol at a concentration of 10 mg/mL. Then,
EGCG/ethanol was used a concentration of 2 % to yield
a maximum concentration of 0.2 mg/mL. LL-37 (se-
quence: LLGDF FRKSK EKIGK EFKRI VQRIK DFLRN
LVPRT ES) powder was synthesized as described previ-
ously using the solid-phase method [30]. Briefly, the
peptide was purified (>99.9 %) by reverse-phase high-
performance liquid chromatography (Model LC-8A;
Shimadzu Corporation, Kyoto, Japan) on a YMC-A 302
column (YMC Co. Ltd., Kyoto, Japan). The final product
was confirmed by electrospray ionization mass spec-
trometry and conserved by suspension in Hank’s
balanced salt solution (HBSS, pH 7.4; Gibco, Grand
Island, NY, USA).
Growth inhibition test
Precultured bacteria were measured at an optical density
(OD) of 660 nm using an ultraviolet/visible spectropho-
tometer (Ubest-35; JASCO Corporation, Tokyo, Japan).
Samples were adjusted to OD660 = 0.5 using BHI broth.
Then, bacteria were diluted to a final concentration of
103–104 Colony-forming unit (CFU)/mL with BHI broth,
and 1 mL of adjusted culture and 1 mL of EGCG solu-
tion were mixed together [28, 31]. The EGCG solution
was prepared by two-fold serial dilution in BHI broth.
Each mixture solution was incubated at 37 °C. The bac-
tericidal activity of EGCG was estimated by measuring
the minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC) at 3, 5, and 24 h
of incubation according to Clinical and Laboratory Stan-
dards Institute 2014 (CLSI) guidelines. After each incu-
bation, 100 μL of EGCG–cell suspension was removed
and inoculated on BHI agar plates. The plates were incu-
bated for 48 h at 37 °C, followed by colony counting
(CFU/mL). Control samples were prepared by mixing
1 mL of bacterial suspension with 0.9 mL of BHI broth
and 0.1 mL of HBSS. The MIC was defined as the lowest
concentration of EGCG that inhibited visible bacterial
growth after overnight incubation. The MBC was de-
fined as the lowest concentration of EGCG that killed
99.9 % of the initial inoculum.
Biofilm formation assays
Biofilm formation was measured under two static con-
ditions using a quantitative crystal violet assay on a
polystyrene 96-well, minimum biofilm eradication con-
centration plate (MBEC; Biosurface Technologies,
Bozeman, MT, USA) as described previously [32]. The
MBEC biofilm assay used 96 polystyrene pegs that fit
the wells of a conventional plate. Briefly, overnight cul-
tures of S. mutans were diluted to OD660 = 0.5 (1 ×
107 CFU/mL) in fresh BHI. Two hundred microliters of
bacterial suspensions were transferred to a 96-well mi-
crotiter plate with 20 μL of varying concentrations of
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EGCG in the presence or absence of LL-37 (final con-
centration of 80 μL/mL). The microtiter plates were
then incubated at 37 °C with shaking for 12, 24, and
36 h. After incubation, the pegs were washed several
times with phosphate buffered solution (PBS) and then
fixed with 200 μL of 100 % ethanol prior to staining for
2 min with 200 μL of 0.41 % (wt/vol) crystal violet in
12 % ethanol (Bio Chemical Sciences, Swedesboro, NJ,
USA). The pegs were washed several times with PBS to
remove excess stain. Quantitative assessment of biofilm
formation was performed by the immersion of pegs in a
sterile microtiter plate containing 200 μL of 100 %
ethanol and incubation at room temperature for
10 min. The absorbance at 550 nm was then deter-
mined. Three independent experiments were performed
for each abovementioned assay.
Biofilm susceptibility assays
To measure the antimicrobial susceptibility of S. mutans
growing in biofilms, the MBEC High-throughput (HTP)
Assay (Innovotech Inc., Edmonton, Alberta, Canada)
was performed [33]. Briefly, overnight cultures of S.
mutans were diluted to OD660 = 0.5 (1 × 10
7 CFU/mL) in
fresh BHI. Then, 200 μL of bacterial suspensions was
transferred to the wells of a MBEC microtiter plate and
the MBEC lid was placed on top of the wells. Biofilms
were grown on the MBEC pegs at 37 °C under shaking
conditions for 24 h. The lid was removed and trans-
ferred to a new plate with wells filled with varying
concentrations of EGCG in the presence or absence of
LL-37 (final concentration of 80 μL/mL), and incubated
for 3 and 5 h at 37 °C. After each incubation, the lid was
gently washed twice with 200 μL of PBS to remove non-
adherent cells. Adherent biofilms were fixed with 200 μL
of 100 % ethanol prior to staining for 2 min with 200 μL
of 0.41 % (wt/vol) crystal violet in 12 % ethanol. The
pegs were washed several times with PBS to remove ex-
cess stain. Quantitative assessment of biofilm formation
was performed by the immersion of pegs in a sterile
polystyrene microtiter plate which contained 200 μL of
100 % ethanol. The plate was incubated at room
temperature for 10 min, then the absorbance at 550 nm
was determined using a microplate spectrophotometer.
Three independent experiments were performed for
each assay.
Field emission-scanning electron microscopy (FE-SEM)
To visualize the effects of EGCG on planktonic bacteria
[28, 31], 10 μL of EGCG solution (0.2 mg/mL) was
plated on a glass slide followed by 10 μL of bacteria
mixed with the solution. This cell suspension was then
incubated at 37 °C for 24 h and dried. Saturated 70 %
ethanol was then applied for 5 min, followed by satu-
rated 100 % ethanol for 5 min, and then the sample was
dried. The sample was then coated with palladium alloy
and examined using FE-SEM (SU8000; Hitachi High-
Technologies Corporation, Tokyo, Japan).
To visualize the effect of EGCG on biofilms, the
MBEC HTP Assay (Innovotech Inc.) was used [28]. Pegs
with adherent biofilms were removed from the MBEC
biofilm assay and rinsed in 0.9 % saline for 1 min to re-
move non-adherent bacteria. The samples were then
fixed with 2.5 % glutaraldehyde (Kanto Chemical Co., Inc.,
Tokyo, Japan) in 0.1 M cacodylic acid (Wako Pure Chem-
ical Industries, Ltd., Miyagi, Japan) at 4 °C for 16 h. The
pegs were washed in 0.1 M cacodylic acid and then
washed once in distilled water for approximately 10 min.
Saturated 70 % ethanol was applied for 15–20 min and
then the sample was air dried for a minimum of 24 h.
Specimens were finally mounted and examined using
FE-SEM.
EGCG, LL-37 and LTA interaction analysis using quartz
crystal microbalance (QCM)
QCM was used to analyze the potential enhancement ef-
fect of LL-37 on binding between EGCG and bacterial
LTA. EGCG was used as a ligand and LTA from S.
mutans (L4152; Sigma-Aldrich, St. Louis, MO, USA)
was used as an analyst. QCM measurements were per-
formed using AFFINIX QN μ (INITIUM Inc., Kanagawa,
Japan). This instrument has a 500-μL cell equipped with
a 27-MHz QCM plate at the bottom of the cell, in
addition to a stirring bar and temperature control sys-
tem. Gold-coated quartz crystal sensor surfaces were
washed twice by mounting 3:1 mixture of concentrated
sulfuric acid and hydrogen peroxide solution for 5 min.
An AFFINIX immobilization kit was then used follow-
ing the manufacturer’s instruction. Briefly, the surfaces
of the sensors were coated with carboxylic acid-
terminated thiol and carboxylic acids were activated as
N-hydroxysuccinimidyl esters as previously described
[34]. Activated carboxyl groups reacted with EGCG
(0.2 mg/mL). After the binding of EGCG to the sensor,
unreacted esters were deactivated using 1 mol ethanol-
amine solution. The amount of LTA solution (10 μg/mL)
and/or LL-37 (80 μg/mL) injected each time was 5 μL
each. HBSS was used as a measurement buffer. The stir-
ring speed was set at 1000 rpm, and experiments were
conducted at 25 °C. Frequency changes in response to the
addition of LTA solution were monitored in real time. As
a control, 10 μg/mL of LTA was injected without initially
binding EGCG on the sensor.
Statistical analysis
Data are presented as the means and standard devia-
tions. Significant differences were determined by the
t-test using Microsoft Excel 2007 (Microsoft Corporation).
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Values were considered to be statistically significant
at p < 0.05.
Results
Short-term antibacterial effect of EGCG on the growth
of S. mutans
In growth inhibition tests, MICs of EGCG for S.
mutans planktonic cells (n = 10) ranged from 0.025 to
0.1 mg/mL; MBCs ranged from 0.1 to 0.4 mg/mL
(Additional file 1: Table S1). To determine the kinet-
ics of the antimicrobial activity of EGCG, bacterial
suspensions were incubated with varying concentra-
tions of EGCG for 3 and 5 h. The percentage of vi-
able bacteria clearly decreased from 64.7 to 4.0 % and
45.3 to 0 % with the treatment of 0.0125–0.2 mg/mL
EGCG after incubation for 3 and 5 h, respectively
(Fig. 1). These results show EGCG has a short-term
bactericidal effect on S. mutans.
Inhibitory effect of EGCG on biofilm formation in the
presence and absence of LL-37
The inhibitory effect of EGCG with or without LL-37
on biofilm formation of S. mutans was measured by
crystal violet staining of pegs in MBEC assays. The
number of biofilm cells on 0.2 mg/mL EGCG with or
without 80 μg/mL LL-37-treated pegs were slightly less
than untreated pegs at 12 h and showed a significantly
decrease after 24- and 36-h incubation (p < 0.05) (Fig. 2).
Moreover, EGCG treatment with LL-37 resulted in less
adherent bacteria than EGCG treatment alone. These
results indicate that the inhibitory effect of EGCG on S.
mutans biofilm formation could be enhanced by the
addition of LL-37.
Inhibitory effect of EGCG on preformed S. mutans
biofilms in the presence and absence of LL-37
The dispersion of preformed biofilms treated with EGCG
was then evaluated using biofilm susceptibility assays.
Streptococcus mutans biofilms were grown on MBEC pegs
and then exposed to 0.2 mg/mL EGCG with or without the
addition of 80 μg/mL LL-37 in fresh media for 3 and 5 h.
After removal of the pegs, the number of viabel bacteria
that remained on the pegs was determined using quan-
titative crystal violet staining. Compared with the
control group, S. mutans preformed biofilms showed
sensitivity to 0.2 mg/mL EGCG treatment, with the
highest sensitivity to EGCG in the presence of 80 μg/
mL LL-37 at 5 h (Fig. 3).
Effect of EGCG on S. mutans cell morphology and
biofilm formation
FE-SEM was used to observe the effect of EGCG on S.
mutans cell morphology and preformed biofilms. As
shown in Fig. 4a, the surface of 0.2 mg/mL EGCG-treated
cells became rough and exhibited broken membranes with
leaked cytoplasm, whereas untreated S. mutans cells were
smooth (Fig. 4b). Microscopic images of S. mutans pre-
formed biofilms on MBEC pegs are shown in Fig. 4c–e,
and whole-cell images of treated cells are shown in Add-
itional file 2: Figure S1. EGCG-treated samples had de-
creased numbers of adherent bacteria and cell membranes
were rough. Moreover, the antibiofilm activity of EGCG




























Fig. 1 Short-term killing assays for EGCG against S. mutans (n = 10). Standardized overnight cultures of S. mutans strains (3000 CFU/mL) were
seeded in a 96-well microtiter plate with varying concentrations of EGCG and incubated for 3 and 5 h at 37 °C. Data are presented as the mean
± SEM from three independent experiments. *, significant difference compared with untreated control (p < 0.05)
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Intermolecular interactions with LTA
The preceding experiments indicated that EGCG likely
binds to a component in the bacterial membrane, and
this interaction could be enhanced by LL-37. Therefore,
we conducted a QCM analysis to determine the precise
interaction(s) between EGCG, LL-37, and LTA. In the
control experiment, the frequency decreased to below
the significance level. The level of decrease caused by
non-specific binding between LTA and the blocking
agent was 12 Hz. When 1 mg/mL LTA was added, the
frequency decreased by 162 Hz, indicating disruption of
the interaction between EGCG and LTA. When 80 μg/
mL of LL-37 was added, the frequency decreased by
313 Hz, indicating an intermolecular interaction be-
tween EGCG and LL-37. After the addition of 1 mg/mL
LTA and 80 μg/mL LL-37, the frequency decreased by
524 Hz. These results suggest that EGCG interacts with
LTA through binding of LL-37.
Discussion
Catechins have a broad spectrum of antimicrobial activ-
ity against both Gram-positive and Gram-negative bac-
teria, especially galloylated derivatives such as EGCG,
which have been documented to possess antimicrobial
effects against oral streptococci [11]. According to our
early study, EGCG demonstrates the highest activity
against S. mutans [28], which also supported by other
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Fig. 3 Biofilm susceptibility assays. Standardized overnight cultures
of S. mutans strains grown on MBEC pegs and incubated overnight
at 37 °C to form mature biofilms. The pegs were immersed in wells
containing 0.2 mg/mL EGCG in the presence or absence of 80 μg/
mL LL-37 for 3 and 5 h to allow the biofilm to disperse from the
pegs to the wells below, and the absorbance was measured. Data are
presented as the mean ± SD from three independent experiments.
























Fig. 2 Biofilm inhibition assay. Standardized overnight cultures of S. mutans strains (n = 10) were grown on MBEC pegs incubated with 0.2 mg/mL
EGCG in the presence or absence of 80 μg/mL LL-37 for 12, 24, or 36 h at 37 °C. Adherent cells were then fixed with ethanol, stained with crystal violet,
eluted with ethanol, and the absorbance was measured. Data are presented as the mean ± SD from three independent experiments. *, significant
difference compared with untreated control (p < 0.05)
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Biofilms increase the ability of bacteria to resist most
antibiotics and therapeutic agents [36]. Stable biofilm
formation is also considered one of the key factors of
caries pathogenesis. In this study, the inhibitory effect of
EGCG on S. mutans planktonic cells, biofilm formation,
and mature biofilms was examined. EGCG was found
to inhibit visible bacterial growth at 0.1 mg/mL, de-
crease biofilm formation, and exhibit a bactericidal
effect on preformed biofilms at 0.2 mg/mL (data not















Fig. 5 Interaction among EGCG, LL-37, and LTA of S. mutans. Graphs show the change in delta frequency after injecting LTA and/or LL-37 on the
sensor of quartz crystal microbalance. Five microliters of LTA (1 mg/mL) and/or LL-37 (8 mg/mL) were injected. The final concentrations of LTA
and LL-37 were 10 and 80 μg/mL, respectively. LTA without initially binding EGCG was injected on the sensor as a control. Data presented are




Fig. 4 Changes in number of planktonic cells and preformed biofilms following incubation of EGCG with/without LL-37. Representative images of
bacterial cells observed by field emission-scanning electron microscope (working distance: 10 mm, field width: 5 μm) are shown. Streptococcus mutans
suspensions incubated in the presence (a) or absence (b) of 0.2 mg/mL EGCG for 24 h. Streptococcus mutans biofilms on MBEC pegs incubated with
0.2 mg/mL EGCG (c), 0.2 mg/mL EGCG, and 80 μg/mL LL-37 (d), or BHI medium (e) for 24 h. The white arrow indicates the “ring” phenomena around
damaged cells
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lower susceptibility to EGCG compared with planktonic
bacteria [20]. We also observed that EGCG treatment
reduced attachment of S. mutans, as previously shown
[21], and caused changes in the cell membrane. Based
on these results, the antimicrobial mechanism of
EGCG is likely attributable to irreversible damage of
the microbial cytoplasmic membrane, as previously
described [37].
LL-37, which is expressed in many tissues and body
fluids, has a broad spectrum of antimicrobial activity
against both Gram-positive and Gram-negative bacteria,
including Staphylococcus aureus and Pseudomonas aeru-
ginosa. In our previous study, we showed that S. mutans
was resistant to LL-37 in growth inhibition and bacteri-
cidal tests, but sensitive to LL-37 during biofilm forma-
tion, which was partly because of binding to LTA [28].
In this study, we observed that EGCG had an inhibitory
effect on S. mutans biofilm formation and reduced the
viability of preformed biofilms, without interacting with
LTA. Therefore, we analyzed the potential cooperative
antibacterial effect of EGCG and LL-37. Our results
showed that LL-37 has no effect on the antibacterial ef-
fect of EGCG on S. mutans planktonic cells (data not
shown), whereas it plays an enhancer role in the inhib-
ition ability of EGCG on preformed biofilms. The num-
ber of bacteria in preformed biofilms was decreased in
the presence of LL-37 compared with EGCG treatment
alone, which was confirmed by FE-SEM. This indicates
that LL-37 may enhance the antibiofilm effect of EGCG
on S. mutans.
To understand the LL-37 enhancement effect on the
antibiofilm activity of EGCG, we subsequently analyzed
the interaction among EGCG, LL-37, and LTA of S.
mutans. EGCG lacked direct interaction with LTA of S.
mutans. In our previous study, we demonstrated that
LL-37 can interact with LTA on S. mutans [28]. In this
study, EGCG and LL-37 exhibited a synergistic antibio-
film effect on S. mutans (Fig. 5). We hypothesize the
two following mechanisms: 1) LL-37 binds to LTA of S.
mutans, enhancing the attachment site of EGCG; or 2)
LL-37 interacts with EGCG, raising the cations on
EGCG and increasing the affinity between EGCG and
LTA, which is supported by Heptinstall et al. [38].
Further studies on the precise mechanism(s) by which
LL-37 enhances the antibiofilm effect of EGCG on S.
mutans are necessary.
Conclusions
Our results indicated that LL-37 can enhance the
antibiofilm effect of EGCG on S. mutans biofilms.
This finding provides new knowledge for dental
treatment by using LL-37 as a potential antibiofilm
compound.
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